Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin (Q41685708)
Jump to navigation
Jump to search
scientific article published on 28 October 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin |
scientific article published on 28 October 2014 |
Statements
1 reference
Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin (English)
1 reference
Julio Rosenstock
1 reference
Lars Hansen
1 reference
Pamela Zee
1 reference
Yan Li
1 reference
William Cook
1 reference
Boaz Hirshberg
1 reference
Nayyar Iqbal
1 reference
28 October 2014
1 reference
1 reference
38
1 reference
3
1 reference
376-383
1 reference
Identifiers
1 reference
1 reference